TRU TruScreen Group Limited
Healthcare · Medical Devices
· website
$0.01
52wk 0.01 – 0.03
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About TruScreen Group Limited
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and the Middle East/North Africa. It offers TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to TruScreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$13.09M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
-0.06
EV / EBITDA
—
Price / Book
5.23
ROE
-125.4%
Operating margin
-48.1%
Net margin
-79.8%
Total cash
$1.46M
Total debt
$200,695
Current ratio
3.29
Debt / Equity
0.08
Free cash flow
$-1.58M
Avg volume
1.34M
Latest annual results
(FY ending 31 Mar 2026)
- Revenue$2.43M
- Gross profit$767.80K
- Operating income-$2.63M
- Net income-$2.25M
- Diluted EPS-0.00
- Free cash flow-$2.47M
- Net debt-$1.26M